2026
Albania’s deputy minister said the 2026 hormone guidance is for adults only.
官方来源
Deputy minister — 2026 hormone guidance is adults-only.
阅读完整更新 →
2025
Andorra funds hormones from 16 and surgery from 18 — under-16s get assessment, not funded hormones.
官方来源
Restricted: Decree 298/2025 public-financing rules — hormones from 16, surgery from 18; under-16s get specialist follow-up.
阅读完整更新 →
2026
目前没有数据。如有官方更新，请通过联系页面给我们发送电子邮件。
阅读完整更新 →
2015
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2026
目前没有数据。如有官方更新，请通过联系页面给我们发送电子邮件。
阅读完整更新 →
2010–2025
Belarus only runs official sex-change/correction for adults in state facilities.
官方来源
Restricted: MoH Resolution 163 (9 December 2010, as amended) is an adult-only state pathway — hormones and/or surgery after an interdepartmental commission. Not an all-ages prohibition like Russia 386-FZ.
阅读完整更新 →
2023–2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2024
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2016
Croatia’s 2016 ministry guidelines allow puberty blockers from early puberty (Tanner stage 2).
官方来源
Ministry of Health expert guidelines (NN 7/2016) set the WPATH (the World Professional Association for Transgender Health)-aligned pathway, including hormones for people with gender dysphoria.
阅读完整更新 →
2010–2022
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2025
A 2025 health-ministry methodology covers gender-incongruence care, including before 18.
官方来源
MoH Metodický pokyn (1 July 2025) standardises legal-sex-change certificates; care may start before 18.
阅读完整更新 →
2023
Denmark is tightening clinical guidance on puberty blockers; there is no legislative ban.
官方来源
Restricted: Sundhedsstyrelsen is revising 2018 clinical guidance toward psychosocial support first — a clinical limit, not a legislative ban.
阅读完整更新 →
2023–2025
The Social Ministry–funded hormone guideline requires adulthood before opposite-sex hormones.
官方来源
Restricted: the Social Affairs Ministry-funded hormone guideline requires adulthood (täisealisus) before hormones for sex-rejecting procedures.
阅读完整更新 →
2020
Finland puts talk therapy first. Hormones for minors, if used, are exceptional.
官方来源
Restricted: COHERE recommends psychosocial support first; hormone treatment, where used, is centralized and exceptional.
阅读完整更新 →
2022
France’s medical academy urged great caution.
官方来源
Mixed: the National Academy of Medicine called for the greatest medical reserve.
阅读完整更新 →
2024
Georgia forbids surgery or other medical manipulation to assign a sex different from biological sex, for people of any age.
官方来源
Officially banned: Family Values law Article 6 forbids surgery or other medical manipulation to assign a different sex (all ages). Not the U.S. state. Art. 6 has no carve-out that leaves puberty blockers legal.
阅读完整更新 →
2025
Germany still allows puberty blockers after strict criteria.
官方来源
Mixed: the 2025 AWMF S2k guideline still permits puberty blockers after Tanner 2 under criteria.
阅读完整更新 →
2017–2021
Law 4491/2017 lets a person from age 15 change the registered sex after an interdisciplinary medical committee.
官方来源
Law 4491/2017 lets a person from 15 correct the registered sex marker after an interdisciplinary medical committee.
阅读完整更新 →
2021
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2019–2020
Iceland’s public pathway can refer under-18s for hormones; permanent genital surgery under 16 is excluded.
官方来源
Gender Autonomy Act; public pathway can refer under-18s for hormones; under-16 permanent genital changes need a physical-health reason.
阅读完整更新 →
2025
Ireland’s health service is writing a new model of care.
官方来源
Under review: the HSE is producing a new Model of Care and reviewing the evidence.
阅读完整更新 →
2024
Italy’s bioethics committee said the evidence on puberty blockers for minors is too weak.
官方来源
Restricted: CNB (22 Nov 2024, published Dec 2024) found evidence for triptorelin in minors with gender dysphoria insufficient; urged Ministry-funded independent trials and hoped prescriptions would sit within those trials.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2013–2024
Latvia does not perform surgical sex-change on minors.
官方来源
Civil-registry sex-marker change requires a medical certificate of sex change. The national children’s hospital has documented puberty blockers for diagnosed adolescents.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2022–2024
Lithuania’s health-ministry protocol covers diagnosis and hormone treatment for adults only.
官方来源
MoH Order V-1307 (4 August 2022) is an adults-only diagnosis and hormone-treatment pathway.
阅读完整更新 →
1978–2016
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2018
Malta’s public pathway includes hormones.
官方来源
LN 44/2018 put gender-identity conditions on the NHS schedule; the public pathway includes hormones.
阅读完整更新 →
2022
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2026
The Health Council left puberty blockers and hormones available after assessment.
官方来源
Health Council 30 June 2026 advice left puberty blockers and hormones available after assessment.
阅读完整更新 →
2013–2025
The health ministry’s 2013 guideline sets an official adult-framed pathway for hormones and surgery.
官方来源
The 2013 Ministry of Health evidence-based-medicine guideline on transsexualism is official medical-pathway guidance, framed for adult sex-change treatment.
阅读完整更新 →
2023
A safety agency called puberty blockers and hormones experimental — a clinical limit, not a legislative ban.
官方来源
Restricted: Ukom recommended treating puberty blockers and hormones as experimental; that is a patient-safety recommendation, not a legislative ban.
阅读完整更新 →
2025
Polish expert guidelines still endorse puberty blockers and hormones for assessed adolescents.
官方来源
Endokrynologia Polska 2025 expert-panel guidelines set puberty suppression and hormones for adolescents after assessment.
阅读完整更新 →
2026
A bill would ban puberty blockers and hormones under 18 — parliament has not made it law.
官方来源
Proposed bill: PL 479/XVII/1ª (generalidade 20 March 2026) would prohibit puberty blockers and hormones under 18.
阅读完整更新 →
2020
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2023
Russia banned medical interventions aimed at changing sex, with an exception for inborn sex-development conditions (DSD).
官方来源
Officially banned: Federal Law 386-FZ (2023) prohibits medical interventions aimed at changing sex, with a congenital/DSD exception.
阅读完整更新 →
2026
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2024
Two NHS boards paused new puberty blockers and hormones for minors — existing patients were not taken off treatment.
官方来源
Restricted: NHS Greater Glasgow and Clyde and NHS Lothian paused new puberty blocker and opposite-sex hormone prescriptions (April 2024).
阅读完整更新 →
2012–2021
The health-insurance fund’s sex-change brochure requires the person to be older than 18.
官方来源
Restricted: RFZO’s published funded sex-change pathway starts at age 18.
阅读完整更新 →
2025
No official pediatric medical policy listed.
官方来源
No official pediatric medical policy listed.
阅读完整更新 →
2022
Slovenia’s public gender-identity council includes child psychiatry and endocrinology.
官方来源
The Advocate of the Principle of Equality’s 2022 special report documents medical confirmation and legal-sex-change procedures in force.
阅读完整更新 →
2026
A Valencian rule on puberty blockers for minors is in court.
官方来源
Mixed: Valencia’s 2025 Ley 8/2017 amendments sit under Constitutional Court suspension.
阅读完整更新 →
2022
Sweden treats puberty blockers and hormones for adolescents as research, not standard care.
官方来源
Restricted to research: Socialstyrelsen recommends puberty suppression and opposite-sex hormones for adolescents only in a research setting, not as standard care.
阅读完整更新 →
2024–2025
Zürich says puberty blockers stay available with specialist assessment.
官方来源
NEK-CNE opinion 43/2024 describes puberty blockade as current practice; Zurich’s health directorate said access to puberty blockers is not being restricted.
阅读完整更新 →
2016
Ukraine’s health-ministry Order 972 is the clinical protocol for gender dysphoria, including hormones.
官方来源
MoH Order 972 (15 September 2016) is the unified clinical protocol for gender dysphoria, including hormones. Child psychiatry is on the pathway.
阅读完整更新 →
2024
No statute bans this. Routine puberty blockers for under-18s stopped after Cass; a puberty blockers trial is ongoing.
官方来源
Restricted: no statute bans this care. NHS England stopped routine puberty blockers for under-18s after Cass; the PATHWAYS puberty blockers trial is ongoing.
阅读完整更新 →
2024
Holy See teaching in Dignitas Infinita rejects gender theory and sex-change interventions.
官方来源
Restricted: Dignitas Infinita §§55–60 rejects gender theory and sex-change interventions. Disorders of sex development (DSD) correction is named separately.
阅读完整更新 →